Viewing Study NCT02494869


Ignite Creation Date: 2025-12-24 @ 10:51 PM
Ignite Modification Date: 2025-12-25 @ 8:21 PM
Study NCT ID: NCT02494869
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-08-27
First Post: 2015-07-08
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Dose-Response of Aerobic Training in Women at High-Risk for Development of Breast Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Study Overview

Official Title: Dose-Response of Aerobic Training in Women at High-Risk for Development of Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Status Verified Date: 2025-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study is being done to look at the effect that different amounts of progressive exercise training has on risk factors associated with developing breast cancer. These risk factors include exercise capacity, body weight, and body composition, as well as the expression of certain genes and levels of inflammatory factors in your breast tissue.

The participant will be instructed to self-report the session information to ExOnc staff at or before their next scheduled visit. If the participant's next scheduled visit is greater than 72 hours following an unsupervised session, ExOnc staff may reach out to the participant to retrieve the session information. Unsupervised session details will be source documented by ExOnc staff.
Detailed Description: None

Study Oversight

Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: